Veterans and Agent Orange: Update 2000 examines the state of the scientific evidence regarding associations between diseases and exposure to dioxin and other chemical compounds in herbicides used in Vietnam. It is the fourth in a series of comprehensive reviews of epidemiologic and toxicologic studies of the agents used as defoliants during the Vietnam War. Over forty health outcomes in veterans and their children are addressed.
Among the report's conclusions is that there is sufficient evidence of a link between exposure and the development of soft-tissue sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and chloracne in veterans. Additionally, it found that scientific studies offer "limited or suggestive" evidence of an association with other diseases in veterans-including Type 2 diabetes, respiratory cancers, prostate cancer, multiple myeloma and some forms of transient peripheral neuropathy-as well as the congenital birth defect spina bifida in veterans' children.
Table of Contents
Front Matter
1 Executive Summary
2 Veterans and Agent Orange: Previous IOM Reports
3 Toxicology
4 Methodological Considerations in Evaluating the Evidence
5 Exposure Assessment
6 Epidemiologic Studies
7 Cancer
8 Reproductive Effects
9 Neurobehavioral Disorders
10 Other Health Effects
Appendix A: Summary of Workshop
Appendix B: ICD-9 Codes for Cancer Outcomes
Appendix C: Committee and Staff Biographies
Index
Sprache
Verlagsort
Zielgruppe
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Maße
Höhe: 240 mm
Breite: 153 mm
Dicke: 43 mm
Gewicht
ISBN-13
978-0-309-07552-7 (9780309075527)
DOI
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Third Biennial Update), Division of Health Promotion and Disease Prevention
1 Front Matter; 2 1 Executive Summary; 3 2 Veterans and Agent Orange: Previous IOM Reports; 4 3 Toxicology; 5 4 Methodological Considerations in Evaluating the Evidence; 6 5 Exposure Assessment; 7 6 Epidemiologic Studies; 8 7 Cancer; 9 8 Reproductive Effects; 10 9 Neurobehavioral Disorders; 11 10 Other Health Effects; 12 Appendix A: Summary of Workshop; 13 Appendix B: ICD-9 Codes for Cancer Outcomes; 14 Appendix C: Committee and Staff Biographies; 15 Index
